Flowflex is a decent at-home COVID test, but it performs best when you have symptoms and a meaningful viral load. In symptomatic people, it correctly identifies about 85-87% of confirmed infections. That’s comparable to most rapid antigen tests on the market, though not the top performer in head-to-head comparisons. Where it falls short is in catching infections early or in people without symptoms.
How Accurate Flowflex Is With Symptoms
When tested against lab-confirmed PCR results, Flowflex detected about 85% of infections in symptomatic people with the Delta variant and roughly 87% with Omicron. Those numbers are solid and in line with what you’d expect from any rapid antigen test. If you’re feeling sick, running a fever, or have a sore throat and the test shows a positive line, you can trust that result. False positives are rare with antigen tests generally.
The key factor is viral load. When people had high levels of virus (the kind you’d typically have a few days into symptomatic illness), Flowflex caught 91-98% of infections depending on the variant. That’s close to a PCR test’s reliability. But when viral load was low, as it is at the very beginning or tail end of an infection, performance dropped dramatically. In one study, Flowflex missed every single low-viral-load Omicron sample tested.
The Weak Spot: Asymptomatic Testing
If you’re testing because you were exposed but feel fine, Flowflex is much less reliable. Its sensitivity in asymptomatic people was only about 24-31% across Delta and Omicron variants. That means it missed roughly two-thirds to three-quarters of infections in people without symptoms. This isn’t unique to Flowflex. Most rapid antigen tests struggle with asymptomatic detection, though some competitors like Roche performed noticeably better (56% for Omicron, 82% for Delta).
This matters if you’re testing before visiting a vulnerable relative or attending a gathering. A single negative Flowflex result without symptoms is not very reassuring on its own.
How It Compares to Other Rapid Tests
In a study published through the National Institutes of Health that compared six rapid antigen tests side by side, Flowflex landed at the lower end of overall sensitivity. Across all patients (symptomatic and asymptomatic combined), it detected about 67-70% of confirmed infections, while competitors like Boson and Roche reached 77-78%. The differences were most pronounced at low viral loads and in asymptomatic testing. For symptomatic people with a solid viral load, the gap between tests narrowed considerably.
So Flowflex isn’t the best rapid test available, but it’s not unreliable either. It performs within the normal range for this category of test. No rapid antigen test matches the accuracy of a PCR test, which remains the gold standard.
How to Get More Reliable Results
A single negative result from any rapid test, Flowflex included, doesn’t rule out infection. The manufacturer’s instructions are specific about repeat testing:
- If you have symptoms: Test again 48 hours after a negative result. That’s two tests over three days.
- If you don’t have symptoms: Test three times total, spacing each test at least 48 hours apart, over five days.
Serial testing significantly improves accuracy because it catches infections as viral load rises. If your first test is negative but you develop symptoms a day later, testing again will often pick up what the first test missed.
Check the Box Before You Use It
Flowflex has a 24-month shelf life, and the FDA has extended expiration dates on some lots. If you have tests sitting in a drawer from a government distribution program, they may still be valid even if the printed date has passed. You can check lot-specific expiration extensions on the FDA’s website for at-home COVID tests.
One important distinction: the FDA-authorized version sold in the U.S. is the “Flowflex COVID-19 Antigen Home Test,” which comes in a specific package. ACON Laboratories issued a recall for a different product, the “Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing),” which is authorized only in Europe under the CE mark and was being sold in the U.S. without FDA authorization. If your box doesn’t match the FDA-authorized version, don’t use it. The authorized U.S. product carries Emergency Use Authorization, not full FDA clearance, which is the same regulatory status as virtually every other at-home COVID test on the market.
The Bottom Line on Flowflex
Flowflex is a functional, widely available rapid COVID test that does its job well in the scenario most people use it for: confirming a suspected infection when you’re already feeling sick. It’s less useful as a screening tool when you feel fine, and it sits toward the lower end of performance compared to some competitors. If accuracy matters most, like before visiting someone immunocompromised, consider serial testing over several days rather than relying on a single result, or opt for a PCR test.